{"entity":{"type":"insider","cik":"0001352620","url":"/insider/0001352620","json_url":"/insider/0001352620.json","name":"Hasnain Faheem","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":56,"n_filings":21,"first":"2006-10-03","last":"2025-12-10","span_basis":"filed_date"},"name_variants":[{"name":"Hasnain Faheem","source":"filing","n_filings":21,"first_seen":"2006-10-03","last_seen":"2025-12-10"}],"transactions":[{"id":4202480,"accession":"0001193125-25-314154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-314154","line_url":"/filing/0001193125-25-314154#line-2","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":10.9764,"price_display":"10.98","price_state":"stated","total_value":109764.0,"total_display":"109,764.00","total_whole":"109,764","shares_owned_after":23983.0,"shares_owned_after_display":"23,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-09","filed_date":"2025-12-10","scope":"insider"},{"id":4616842,"accession":"0000950170-25-043903","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-043903","line_url":"/filing/0000950170-25-043903#line-2","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22682.0,"shares_display":"22,682","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":181456.0,"total_display":"181,456.00","total_whole":"181,456","shares_owned_after":23983.0,"shares_owned_after_display":"23,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-24","scope":"insider"},{"id":2125176,"accession":"0001728117-24-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001728117-24-000076","line_url":"/filing/0001728117-24-000076#line-1","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":372000.0,"shares_display":"372,000","price_per_share":0.6728,"price_display":"0.67","price_state":"stated","total_value":250281.6,"total_display":"250,281.60","total_whole":"250,282","shares_owned_after":5408073.0,"shares_owned_after_display":"5,408,073","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-21","filed_date":"2024-06-24","scope":"insider"},{"id":2227506,"accession":"0001728117-24-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001728117-24-000037","line_url":"/filing/0001728117-24-000037#line-1","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23172.0,"shares_display":"23,172","price_per_share":1.1554,"price_display":"1.16","price_state":"stated","total_value":26772.9288,"total_display":"26,772.93","total_whole":"26,773","shares_owned_after":120293.0,"shares_owned_after_display":"120,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-03-28","scope":"insider"},{"id":7871130,"accession":"0001209191-23-045653","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-045653","line_url":"/filing/0001209191-23-045653#line-1","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10791.0,"shares_display":"10,791","price_per_share":27.8,"price_display":"27.80","price_state":"stated","total_value":299989.8,"total_display":"299,989.80","total_whole":"299,990","shares_owned_after":10791.0,"shares_owned_after_display":"10,791","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-14","scope":"insider"},{"id":7823272,"accession":"0001728117-23-000018","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001728117-23-000018","line_url":"/filing/0001728117-23-000018#line-3","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":440500.0,"shares_display":"440,500","price_per_share":1.1432,"price_display":"1.14","price_state":"stated","total_value":503579.6,"total_display":"503,579.60","total_whole":"503,580","shares_owned_after":4495897.0,"shares_owned_after_display":"4,495,897","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-22","filed_date":"2023-03-22","scope":"insider"},{"id":7823268,"accession":"0001728117-23-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001728117-23-000018","line_url":"/filing/0001728117-23-000018#line-2","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":269389.0,"shares_display":"269,389","price_per_share":1.1965,"price_display":"1.20","price_state":"stated","total_value":322323.9385,"total_display":"322,323.94","total_whole":"322,324","shares_owned_after":4055397.0,"shares_owned_after_display":"4,055,397","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-21","filed_date":"2023-03-22","scope":"insider"},{"id":7823264,"accession":"0001728117-23-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001728117-23-000018","line_url":"/filing/0001728117-23-000018#line-1","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":168683.0,"shares_display":"168,683","price_per_share":1.0344,"price_display":"1.03","price_state":"stated","total_value":174485.6952,"total_display":"174,485.70","total_whole":"174,486","shares_owned_after":3786008.0,"shares_owned_after_display":"3,786,008","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-22","scope":"insider"},{"id":6260788,"accession":"0001728117-22-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001728117-22-000059","line_url":"/filing/0001728117-22-000059#line-1","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":138696.0,"shares_display":"138,696","price_per_share":7.21,"price_display":"7.21","price_state":"stated","total_value":999998.16,"total_display":"999,998.16","total_whole":"999,998","shares_owned_after":3617325.0,"shares_owned_after_display":"3,617,325","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-15","filed_date":"2022-07-15","scope":"insider"},{"id":6402719,"accession":"0001728117-22-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001728117-22-000031","line_url":"/filing/0001728117-22-000031#line-1","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19035.0,"shares_display":"19,035","price_per_share":8.915,"price_display":"8.92","price_state":"stated","total_value":169697.025,"total_display":"169,697.02","total_whole":"169,697","shares_owned_after":143465.0,"shares_owned_after_display":"143,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-23","filed_date":"2022-03-24","scope":"insider"},{"id":3018573,"accession":"0001209191-20-054841","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-054841","line_url":"/filing/0001209191-20-054841#line-1","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":96520.0,"shares_display":"96,520","price_per_share":10.3605,"price_display":"10.36","price_state":"stated","total_value":999995.46,"total_display":"999,995.46","total_whole":"999,995","shares_owned_after":3478629.0,"shares_owned_after_display":"3,478,629","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-14","filed_date":"2020-10-14","scope":"insider"},{"id":8351531,"accession":"0001209191-19-050928","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-050928","line_url":"/filing/0001209191-19-050928#line-1","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":16.798,"price_display":"16.80","price_state":"stated","total_value":167980.0,"total_display":"167,980.00","total_whole":"167,980","shares_owned_after":3382109.0,"shares_owned_after_display":"3,382,109","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-27","filed_date":"2019-09-27","scope":"insider"},{"id":7926987,"accession":"0001209191-19-033882","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-033882","line_url":"/filing/0001209191-19-033882","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Tocagen Inc","issuer_ticker":"TOCA","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43000.0,"shares_display":"43,000","price_per_share":4.658477139534884,"price_display":"4.66","price_state":"stated","total_value":200314.517,"total_display":"200,314.52","total_whole":"200,315","shares_owned_after":241717.0,"shares_owned_after_display":"241,717","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-30","filed_date":"2019-06-03","scope":"insider","n_lines":3},{"id":6053700,"accession":"0001280776-18-000088","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001280776-18-000088","line_url":"/filing/0001280776-18-000088","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"VITAL THERAPIES INC","issuer_ticker":"VTL","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":177443.0,"shares_display":"177,443","price_per_share":0.43776663717362757,"price_display":"0.44","price_state":"stated","total_value":77678.6254,"total_display":"77,678.63","total_whole":"77,679","shares_owned_after":4500.0,"shares_owned_after_display":"4,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-13","filed_date":"2018-09-17","scope":"insider","n_lines":2},{"id":4760611,"accession":"0001280776-17-000092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001280776-17-000092","line_url":"/filing/0001280776-17-000092#line-1","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"VITAL THERAPIES INC","issuer_ticker":"VTL","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":59200.0,"shares_display":"59,200","price_per_share":4.187,"price_display":"4.19","price_state":"stated","total_value":247870.4,"total_display":"247,870.40","total_whole":"247,870","shares_owned_after":181943.0,"shares_owned_after_display":"181,943","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-14","filed_date":"2017-09-15","scope":"insider"},{"id":4777695,"accession":"0001209191-17-027904","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-027904","line_url":"/filing/0001209191-17-027904#line-2","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Tocagen Inc","issuer_ticker":"TOCA","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","total_whole":"1,000,000","shares_owned_after":202857.0,"shares_owned_after_display":"202,857","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-19","filed_date":"2017-04-21","scope":"insider"},{"id":2336522,"accession":"0001280776-16-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001280776-16-000016","line_url":"/filing/0001280776-16-000016#line-1","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"VITAL THERAPIES INC","issuer_ticker":"VTL","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":118243.0,"shares_display":"118,243","price_per_share":5.92,"price_display":"5.92","price_state":"stated","total_value":699998.56,"total_display":"699,998.56","total_whole":"699,999","shares_owned_after":122743.0,"shares_owned_after_display":"122,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-12","filed_date":"2016-08-15","scope":"insider"},{"id":6532092,"accession":"0001209191-14-068344","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-068344","line_url":"/filing/0001209191-14-068344#line-2","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Receptos, Inc.","issuer_ticker":"RCPT","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63205.0,"shares_display":"63,205","price_per_share":108.99,"price_display":"108.99","price_state":"stated","total_value":6888712.95,"total_display":"6,888,712.95","total_whole":"6,888,713","shares_owned_after":387409.0,"shares_owned_after_display":"387,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-11","filed_date":"2014-11-12","scope":"insider"},{"id":6532088,"accession":"0001209191-14-068344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-068344","line_url":"/filing/0001209191-14-068344#line-1","is_derivative":false,"issuer_cik":"0001352620","issuer_name":"Receptos, Inc.","issuer_ticker":"RCPT","issuer_name_source":null,"issuer_url":"/issuer/0001352620","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136795.0,"shares_display":"136,795","price_per_share":109.69,"price_display":"109.69","price_state":"stated","total_value":15005043.55,"total_display":"15,005,043.55","total_whole":"15,005,044","shares_owned_after":450614.0,"shares_owned_after_display":"450,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-10","filed_date":"2014-11-12","scope":"insider"},{"id":3858835,"accession":"0001209191-08-042084","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-08-042084","line_url":"/filing/0001209191-08-042084","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Officer (EVP, Oncology/Rheumatology SBU)","role_mark":"O","role_mark_label":"Officer (EVP, Oncology/Rheumatology SBU)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Oncology/Rheumatology SBU","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36837.0,"shares_display":"36,837","price_per_share":62.073595966012434,"price_display":"62.07","price_state":"stated","total_value":2286605.0546,"total_display":"2,286,605.05","total_whole":"2,286,605","shares_owned_after":41254.2214,"shares_owned_after_display":"41,254.22","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-09","filed_date":"2008-07-10","scope":"insider","n_lines":2},{"id":3801148,"accession":"0001209191-08-023622","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001209191-08-023622","line_url":"/filing/0001209191-08-023622","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Officer (EVP, Oncology/Rheumatology SBU)","role_mark":"O","role_mark_label":"Officer (EVP, Oncology/Rheumatology SBU)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Oncology/Rheumatology SBU","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6425.0,"shares_display":"6,425","price_per_share":64.46816186770428,"price_display":"64.47","price_state":"stated","total_value":414207.94,"total_display":"414,207.94","total_whole":"414,208","shares_owned_after":35541.2214,"shares_owned_after_display":"35,541.22","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-08","filed_date":"2008-04-10","scope":"insider","n_lines":25},{"id":9263565,"accession":"0001209191-07-032701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-032701","line_url":"/filing/0001209191-07-032701#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001352620","owner_name":"Hasnain Faheem","owner_display_name":"Hasnain Faheem","owner_url":"/insider/0001352620","role":"Officer (SVP, Oncology SBU)","role_mark":"O","role_mark_label":"Officer (SVP, Oncology SBU)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Oncology SBU","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7446.0,"shares_display":"7,446","price_per_share":49.0,"price_display":"49.00","price_state":"stated","total_value":364854.0,"total_display":"364,854.00","total_whole":"364,854","shares_owned_after":26205.18,"shares_owned_after_display":"26,205.18","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-23","filed_date":"2007-05-24","scope":"insider"}],"collapsed":true,"next_cursor":"2007-05-23|9263565","ledger_fault":false,"count":{"value":56,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":14,"open_market":true},{"code":"S","label":"Open-market sale","n":42,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":56},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001422143","name":"Kura Oncology, Inc.","url":"/issuer/0001422143","role":"Director","n_filings":2,"first_seen":"2025-03-24","last_seen":"2025-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001728117","name":"Gossamer Bio, Inc.","url":"/issuer/0001728117","role":"Director, Officer (President & CEO)","n_filings":7,"first_seen":"2019-09-27","last_seen":"2024-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Director","n_filings":1,"first_seen":"2023-08-14","last_seen":"2023-08-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001419041","name":"Tocagen Inc","url":"/issuer/0001419041","role":"Director","n_filings":2,"first_seen":"2017-04-21","last_seen":"2019-06-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001280776","name":"VITAL THERAPIES INC","url":"/issuer/0001280776","role":"Director","n_filings":3,"first_seen":"2016-08-15","last_seen":"2018-09-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001463729","name":"Receptos, Inc.","url":"/issuer/0001463729","role":"Director, Officer (President & CEO)","n_filings":1,"first_seen":"2014-11-12","last_seen":"2014-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0000875045","name":"BIOGEN IDEC INC.","url":"/issuer/0000875045","role":"Officer (EVP, Oncology/Rheumatology SBU)","n_filings":5,"first_seen":"2006-10-03","last_seen":"2008-07-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001352620","retrieved_at":"2026-08-26T00:09:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}